News Focus
News Focus
icon url

researcher59

05/14/26 9:46 AM

#130585 RE: gilead23 #130583

CRMD +.70 to 8.20, sales of their primary product DefenCath, 76% of Q1 revenues, are expected to taper off quickly, but evidently investors like the pipeline.

PR -

DefenCath continues to exceed expectations despite pending TDAPA expiration and demonstrates strong underlying utilization demand.

Google -

TDAPA stands for Transitional Drug Add-on Payment Adjustment. • TDAPA coverage usually is for two years. • Medicare will reimburse drugs that have applied for TDAPA and are still under that contract, the. average sale price of the drug plus the dispensing cost.